The Drugs Controller General of India (DCGI) has granted approval to Entod Pharmaceuticals’ innovative PresVu eye drops, ...
The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of COVID-19 vaccine Covovax as a booster dose in adults, official sources said.
The recommendation has been sent to Drugs Controller General of India (DCGI) for final approval. The application for emergency use authorisation was submitted by Prakash Kumar Singh, director ...
New Delhi, Mar 5 () Zydus Cadila has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results